Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.61), $1.10 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $24.5 million versus the consensus estimate of $106.5 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.